콘텐츠로 건너뛰기
Merck
  • Proteasome selectivity towards Michael acceptor containing oligopeptide-based inhibitors.

Proteasome selectivity towards Michael acceptor containing oligopeptide-based inhibitors.

Organic & biomolecular chemistry (2010-05-08)
Wouter A van der Linden, Paul P Geurink, Chris Oskam, Gijsbert A van der Marel, Bogdan I Florea, Herman S Overkleeft
초록

The synthesis and biological evaluation of ten Michael acceptors containing potential proteasome inhibitors are described. Cellular targets of azide containing inhibitors and were assessed in HEK293T and RAW264.7 cells by a two step labeling strategy, followed by biotin-pulldown, affinity purification, on-bead tryptic digestion and LC-MS(2) identification. This strategy appears to be an attractive alternative to gel-based competition assays.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
O-(6-Chlorobenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, ≥98.0% (HPLC)